Status:
COMPLETED
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
Lead Sponsor:
University of Rochester
Conditions:
Asthma
Erythema Toxicum Neonatorum
Eligibility:
All Genders
3-9 years
Brief Summary
Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic ...
Eligibility Criteria
Inclusion
- Children between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years.
- Control subjects will be age matched and without an asthma diagnosis.
Exclusion
- Children without accessible medical records
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT00178152
Start Date
May 1 2005
End Date
November 1 2005
Last Update
May 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, University of Rochester
Rochester, New York, United States, 14642